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Drug-drug interactions and adverse drug reactions in polypharmacy 
among older adults: an integrative review1
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Objective: to identify and summarize studies examining both drug-drug interactions (DDI) and 
adverse drug reactions (ADR) in older adults polymedicated. Methods: an integrative review of 
studies published from January 2008 to December 2013, according to inclusion and exclusion 
criteria, in MEDLINE and EMBASE electronic databases were performed. Results: forty-seven full-
text studies including 14,624,492 older adults (≥ 60 years) were analyzed: 24 (51.1%) concerning 
ADR, 14 (29.8%) DDI, and 9 studies (19.1%) investigating both DDI and ADR. We found a variety 
of methodological designs. The reviewed studies reinforced that polypharmacy is a multifactorial 
process, and predictors and inappropriate prescribing are associated with negative health outcomes, 
as increasing the frequency and types of ADRs and DDIs involving different drug classes, moreover, 
some studies show the most successful interventions to optimize prescribing. Conclusions: DDI 
and ADR among older adults continue to be a significant issue in the worldwide. The findings from 
the studies included in this integrative review, added to the previous reviews, can contribute to the 
improvement of advanced practices in geriatric nursing, to promote the safety of older patients in 
polypharmacy. However, more research is needed to elucidate gaps.
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Introduction
The world is on the brink of a demographic 
milestone. In about five years’ time, the number of 
people aged 65 or older will outnumber children under 
age 5. Driven by falling fertility rates and remarkable 
increases in life expectancy, population ageing will 
continue, even accelerate. The number of people aged 
65 or older is projected to grow from an estimated 524 
million in 2010 to nearly 1.5 billion in 2050, with most of 
the increase in developing countries(1).
Ageing, one of the most complex biological 
phenomena, is a multifaceted process in which several 
physiological changes occur at both the tissue and the 
whole-organism level, occurring in cascade, especially 
post-reproduction(2). The changes characterized by 
ageing include: changes in biochemical composition 
of tissues; progressive decrease in physiological 
capacity; reduced ability to adapt to stimuli; increased 
susceptibility and vulnerability to disease and increased 
risk of death(3). 
Age related chronic diseases such as dyslipidemia, 
hypertension, diabetes, and depression usually require 
the use of multiple drugs, a state known as polypharmacy. 
This refers to the use of multiple medications and/
or more medications than clinically indicated. It is 
estimated that more than 40% of adults aged 65 or 
older use 5 or more medications, and 12% use 10 or 
more different medications(4). However, the magnitude 
of the problem among older adults is still scarcely known 
in most countries.
It is well known in the literature that polypharmacy 
increases the use of inappropriate drugs, leading to the 
underuse of essential medicines for the appropriate 
control of conditions prevalent in the older adults. In 
addition, it sets up a barrier to treatment adherence 
in that it creates complex therapeutic regimens, and 
enables the occurrence of medication errors, drug-drug 
interactions, adverse reactions, and poor quality of life. 
It increases morbidity, mortality, and complexity of care. 
It also imposes a huge financial burden on both the older 
adults and health system(5). 
Furthermore, attention should be paid to the fact 
that the body of the older adults presents changes 
in their physiological functions that may lead to a 
differentiated pharmacokinetics and greater sensitivity 
to both therapeutic and adverse drug effects(5). 
Pharmacokinetics, pharmacodynamics, and clinical 
outcomes are affected by a number of patient-specific 
factors, including age, sex, ethnicity, genetics, disease 
processes, polypharmacy, drug dose and frequency, 
social factors, and many other factors(6). 
The scenario above highlights that population 
ageing is a global phenomenon and the practice of 
polypharmacy is dangerous for patients, in particular 
for older adults, because favors the emergence of drug-
drug interactions (DDI), adverse drug reactions (ADR), 
side effects, longer hospital stays, iatrogenic disease 
and may also lead to complications that induce the 
patient’s death. Thus, the purpose of the present study 
was to conduct a broader integrative review aimed at 
identifying and summarizing studies examining both 
DDIs and ADRs in older adults polymedicated.
Methods
The stages of this integrative review include: 
problem identification, formulating the appropriate 
question to be investigated; literature search with 
selection of articles according to predetermined criteria; 
data evaluation extracting data from each study 
summary of results; data analysis and presentation 
of results(7). The following describes the steps of the 
integrative review for this study.
To elaborate the guiding question was applied to 
the PICO strategy defining population “older adults”, 
intervention “use of multiple medications/polypharmacy” 
and outcome “occurrence of drug interactions and 
adverse drug reactions”. Thus, the central question 
of this integrative review was: What is the scientific 
evidence available, demonstrating the occurrence of 
drug-drug interactions and adverse drug reactions in 
older (i.e. ≥60 years of age) polymedicated adults? 
For the selection of articles, studies published in 
the English, Spanish and Portuguese languages in the 
period between January 2008 and December 2013 were 
eligible. The time period was based on the existence of 
two previous literature reviews. One in which investigated 
observational studies examining the epidemiology of 
polypharmacy, reviewing randomized controlled studies 
that have been published in the past 2 decades (from 
1986 until June 2007) designed to reduce polypharmacy 
in older adults(8); and, another review who reviewed 
the body of literature addressing polypharmacy in 
individuals aged 60 years and older, between January 
1991 and October 2003, to (a) determine primary care 
providers’ definition of polypharmacy, (b) explore how 
polypharmacy was assessed in primary care, and (c) 
seek tested interventions that address polypharmacy(9). 
Additionally, studies obtained from primary sources, 
represented by original scientific articles, surveys that 
have shown data on the occurrence of DDI and ADR 
in older adults (≥ 60 years of age), female and male 
sex, were on multiple medications (polypharmacy) were 
selected. The following were excluded from this review: 
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articles on drug-disease, drug-food, drug-alcohol 
interactions and drug-nutritional status, abstracts, 
case study articles, news, commentary, reflection, 
systematic review articles, clinical updates, expert 
opinion, studies concomitantly involving child (birth - 18 
years), adults (≥19 years), middle aged (≥45 years) 
and older people (≥ 60 years), research with qualitative 
approach, editorials, consensus, study protocols, clinical 
guidelines, reviews, short communication, monographs, 
theoretical studies and economic evaluation studies and 
articles published before 2008.
The following bibliographic databases were 
researched: International Medical Literature Analysis 
and Retrieval System Online (MEDLINE) via PubMed 
and EMBASE. In these databases were used Medical 
Subject Headings Terms (MeSH) and Emtree terms. 
The main descriptors adopted in the search strategy for 
primary studies were: older adults, polypharmacy, drug 
interactions, adverse drug reactions and aged, combined 
using the Boolean operators AND and OR.
After searched, all articles were screened by reading 
their title, abstract and, when necessary, the content 
briefly, and, thereby, identifying those papers potentially 
addressing the topic. The selected articles were analyzed 
initially and in a second stage, they were read in more 
detail regarding their content. Finally, the selected 
articles had their data synthesized. To summarize the 
data of the selected articles and aiming to ensure that all 
relevant information was extracted, we applied to each 
study a validated instrument by Ganong(10). 
In order to determine the relevance of articles 
captured in the searched databases, two examiners 
performed the synthesis of the data of interest 
independently which was followed by the thematic 
analysis of the papers. Each item synthesized/recorded 
in the instrument was filed in Microsoft Word® 2007, 
generating a database. All disagreements were resolved 
by discussion.
The results and data analysis are presented in 
descriptive form.
Results
A total of 409 references were identified and forty-
seven were included in the final analysis. For details, see 
the flow diagram (Figure 1). 
Figure 1 - Flow diagram of the articles screened, assessed for eligibility, included and excluded. London, United 
Kingdom, 2013
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The articles analyzed were from different countries: 
9 from (19.1%) the United States, 7 (14.9%) from 
Canada, 6 (12.8%) from Brazil, 4 (8.5%) from Ireland, 
3 (6.4%, respectively) from Belgium and India, 2 (4.3%, 
respectively) from Australia, Croatia, Spain, Norway 
and 1 (2.1%, respectively) from France, Indonesia, 
Netherlands, Singapore, Switzerland, Sweden, Taiwan. 
Regarding language, 46 (97.9%) articles were written in 
English and only one (2.1%) in Spanish. Descriptive and 
analytical studies have been included: cross-sectional 
(n=9; 19.1%), followed by cohort studies (n=7; 14.9%), 
nested case-control (n=6; 12.8%) and prospective and 
prospective observational (n=5; 10.6%, respectively), 
among others. Considering all the 47 articles examined, 
a total of 14,624,492 older adults/patients (≥ 60 years) 
were included, predominantly of hospitals (n=22 articles; 
45.8%). Concerning the authorship of publications, 31 
(66.0%) are of multidisciplinary researchers, 8 (17.0%) 
from pharmacists, 7 (14.9%) from physicians and 1 
(2.1%) from dentists.
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Examined the risk of bleeding 
associated with exposure to all 
antibiotic agents combined as well 
as several specific antibiotic agents 
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risk score in terms of its clinical 
applicability, and its ability to 
predict ADRs in hospitalized older 
patients when compared with expert 
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Cross-sectional 
observational study
Examine: (a) types of drugs used 
and presence of DDIs, (b) drug 
adherence, (c) patient knowledge of 
the purpose of their drugs and (d) 
practical drug management capacity.
n=338 
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Describe the prevalence of unplanned 
hospitalizations caused by ADRs in 
older veterans, and to examine the 
association between this outcome 
and polypharmacy after controlling 











Improve the use of benzodiazepines 
in the older adults by pharmacist-
physician collaboration, and to insure 













Investigate the incidence of DDIs 
related to ADRs in older outpatients 
who attended public primary 
healthcare units in a southeastern 
region of Brazil; and, to investigate 
the possible predictors of DDI-related 
ADRs.
n=443 patients
Exposed (n=28, 80.3 ±7.1 
years) and non-exposed 
group (n=405, 65.9 ±3.4 
years)
(the Figure 2 continue in the next page...)
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Investigate the prevalence of clinically 
important potential DDIs in older 
patients attending the public primary 
health care system in Brazil; and, 
to investigate possible predictors of 
potential DDIs.
n=12,343 Exposed 
(n=5,855 63.31 ±3.47 
years) and unexposed 
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Assess the effect of an intervention 
on drug-related problem (ADR, 
adherence problems, underuse), 
readmission rates in older adults.
n=665 (intervention group 
n=317 and control group 
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Identify the frequency of drug-related 
problem among patients presenting 
to the emergency department with 
non-specific complaints, such as 
generalized weakness and to evaluate 













Evaluate the incidence and type of 
actual DDIs that result in ADRs or 
diminished therapeutic effect in older 
adults within 30 days of discharge 












Examine the impact of a new model 
of care, in which a clinical pharmacist 
conducts structured medication 
reviews and a multi-professional team 
collates systematic medication care 
plans, on the number of unidentified 
drug-related problem.
n=141 
(intervention group  
n=70, 81,9 ±7.5 years 






Centre Singapore Prospective study
Identify common drug-related problem 
among older cancer patients, to 
determine the effectiveness of 
medication therapy management 
service in resolving drug-related 
problem, to determine the clinical 
significance of pharmacist 










wards of three 
hospitals 
Cohort study
Assess medical teams’ ability to 












Evaluate the type, acceptance rate, 




(SD: 6.65; median: 82 
years)
Figure 2 – Articles revised according to their characteristics. Brasilia, Federal District, Brazil, 2014
*IQR – Interquatile Range; †SD – Standard Derivation




Tool of Older Persons’ potentially inappropriate Prescriptions criteria identified 336 potentially inappropriate medicines 
affecting 247 patients (35%), of whom one-third (n=82) presented with an associated ADR.  Beers’ criteria identified 226 
potentially inappropriate medicines affecting 177 patients (25%), of whom 43 presented an associated ADR.
(the Figure 3 continue in the next page...)
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Patients taking >5 medications were 3.3 times more likely to receive an inappropriate medication than those taking 
≤5 medications.  49% of patients with inappropriate prescriptions were admitted to hospital with adverse effects to the 
inappropriate medications. There was no association between gender and age.
Zhang et al.
Australia, 2009(13) 
5,056 (17.7%) patients had a repeat admission for an ADR. Comorbid congestive cardiac failure, peripheral vascular 
disease, chronic pulmonary disease, rheumatologic disease, mild liver disease, moderate to severe liver disease, 
moderate diabetes, diabetes with chronic complications, renal disease, any malignancy including lymphoma and 
leukemia, and metastatic solid tumors were strong predictive factors. 
Juurlink et al.
Canada, 2009(14) 
Among 13,636 patients receiving clopidogrel following acute myocardial infarction, 734 cases were identified, readmitted 
with myocardial infarction and 2,057 controls. The use of proton pump inhibitors was associated with an increased risk 
of re-infarction.  
Rassen et al.
U.S, 2009(15) 
On a pooled basis, 2.6% of those who also initiated a proton pump inhibitors vs 2.1% of  proton pump inhibitors non 
users had a myocardial infarction hospitalization; 1.5% vs 0.9% died, and 3.4% vs 3.1% underwent revascularization. 
Miquel et al.
Spain, 2010(16) 
Screening Tool of Older Persons’ potentially inappropriate Prescriptions criteria detected potentially inappropriate 
medicines in 36% (primary care), 54% (hospital geriatric assessment outpatient clinic) and 50% (nursing home) of 
the subjects. Beers’ criteria detected potentially inappropriate drugs in 24% (primary care), 26% (hospital geriatric 
assessment outpatient clinic) and 20% (nursing home) of the subjects.  
Weir et al.
Canada, 2010(17) 
Compared with amoxicillin, the use of trimethoprim/sulfamethoxazole was associated with a substantially greater risk of 
hyperkalemia requiring hospital admission. When dosing was considered, the association was greater at higher doses 
of trimethoprim/sulfamethoxazole. When the primary analysis was repeated in a cohort of non β-blocker users, the risk 




Of 2,430 women treated with tamoxifen and a single selective serotonin reuptake inhibitor, 374 (15.4%) died of breast 
cancer during follow-up. After adjustment for age, duration of tamoxifen treatment, and other potential confounders, 
absolute increases of 25%, 50%, and 75% in the proportion of time on tamoxifen with overlapping use of paroxetine 
were associated with 24%, 54%, and 91% increases in the risk of death from breast cancer. 
Somers et al.
Australia, 2010(19) 
Polypharmacy was identified in 91.2%. 50.4% were found to be taking at least one potentially inappropriate medication. 




Polypharmacy was observed in 44.5% and 90.4% of patients at admission and during hospital stay. A total of 360 ADRs 
were observed in 292 patients. The increased number (≥9) of concurrent medications’ use during hospital stay was 
found as the only influential predictor of potentially inappropriate medication use. Gender, age, number of diseases and 




Were identified 215 drug combinations with the potential to cause clinically significant interaction, out of which 83.3% 
had clinical significance C (specified agents may interact in a clinically significant manner; monitoring therapy is 
suggested), 16.3% clinical significance D (the two medications may interact in a clinically significant manner), and 0.4% 




Of the 100 cases, 65 % cases had experienced potential DDIs range from 1 to 17. Of total 204 DDIs incidences, 25% 
were of significance level 1 and 39% of significance level 2. The study showed that the number of potential DDIs 
increased as the number of medications used per day increased. Geriatric patients taking nine or more medication 
tended to have more DDIs (6.8±5.5) in comparison to those with one to two medications. 
Wright et al.
Canada, 2011(23)
Of the 7,100 patients admitted to hospital because of hypotension while receiving a calcium-channel blocker, 176 
had been prescribed a macrolide antibiotic during either the risk or control intervals. Erythromycin was most strongly 




Over the one-year study period, 126 patients (33%) developed 167 adverse drug events. The risk of adverse drug 
events was not associated with any of the geriatric conditions, and the strongest factor associated with adverse drug 




Over the 12-month follow-up period, 497 ADRs occurred in 269 participants, including 187 ADRs considered preventable 
and 127 considered severe. Many geriatric conditions were not associated with risk of ADRs.
Santos et al.
Brazil, 2011(26) 
The 36 possible ADRs found were related to gastrointestinal tract, skin and the nervous system. A total of 63 DDIs were 




Prescriptions with 2 to 3 (39%), 4 to 5 (88.8%) and 6 to 7 (100%) medications showed potential DDIs.
(the Figure 3 continue in the next page...)
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During the 18 year study period, 6,903 admissions for hyperkalemia were identified, 306 of which occurred within 14 
days of antibiotic use. Of these, 248 (81%) cases were matched to 783 controls. 10.8% of spironolactone users received 
at least one prescription for trimethoprim/sulfamethoxazole. Compared with amoxicillin, prescription of trimethoprim/
sulfamethoxazole was associated with a marked increase in the risk of admission to hospital for hyperkalemia. 
Varallo et al.
Brazil, 2011(29) 
Were reported 167 different drugs, of which 58 were responsible for 99 ADRs. Of these ADRs, 4 were related to the use 
of potentially inappropriate medicines, 82 to the use of drugs other than potentially inappropriate medicines and 13 of 
both categories of drugs (potentially inappropriate medicines and non potentially inappropriate medicines). The majority 
(57.6%) of ADRs identified were classified as “possible”.
Gallagher et al.
Ireland, 2011(30) 
Prescription of medications with potential for clinically important DDIs was significantly reduced in the intervention group 
at discharge and during follow-up.
Hanlon et al.
U.S, 2011(31)
Among depressed patients who received antidepressants, 43.1% had potential inappropriate use due primarily to 
problems seen with drug-drug and drug-disease interactions.
Skaar and O’Connor
U.S, 2011(32)
Were identified 25 DDIs of clinical importance in ambulatory settings. The potential serious interactions included aged 




Number of interactions: Average: 1.19 (SD: 2.23)




Among 58,429 older people receiving phenytoin, were identified 796 case patients hospitalized for phenytoin toxicity 
and 3,148 matched controls. Following multivariable adjustment for potential confounders, were observed a more 
than doubling of the risk of phenytoin toxicity following the receipt of trimethoprim/sulfamethoxazole. In contrast, were 
observed no such risk with amoxicillin.
Budnitz et al.
U.S, 2011(35)
On the basis of 5,077 cases identified in the sample, there were an estimated 99,628 emergency hospitalizations for 
adverse drug events in United States. Emergency department visits that resulted in hospitalization, as compared with 
visits that did not result in hospitalization, were more likely to involve unintentional overdoses (65.7%  vs. 45.7%) and 
five or more concomitant medications (54.8% vs. 39.9%). Four medications or medication classes were implicated 
alone or in combination in 67.0% of hospitalizations: warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), 




54,038 (89.0%) patients received at least one prescription for an antidepressant during follow-up. Selective serotonin 
reuptake inhibitors were associated with the highest adjusted hazard ratios for falls and hyponatraemia compared 
with when antidepressants were not being used. The group of other antidepressants was associated with the highest 
adjusted hazard ratios for all cause mortality, attempted suicide/self harm, stroke/transient ischemic attack, fracture, and 
epilepsy/seizures, compared with when antidepressants were not being used. 
Chan et al.
Taiwan, 2012(37)
Problem domain: interactions (2 categories) (12%). Category: potential interaction (12%). Problem domain: adverse 




Exposure to any antibiotic agent within the 15 days of the event/index date was associated with an increased risk of 
bleeding. All six specific antibiotic drug classes examined [azole antifungals, macrolides, quinolones, cotrimoxazole, 




In-hospital ADRs were identified in 135 patients (26%). Variables which increased ADR risk include (i) renal failure, (ii) 
increasing number of medications, (iii) inappropriate medications and (iv) age ≥75 years.
Somers et al.
Belgium, 2012(40)
The number of drugs was significantly correlated with higher Medication Appropriateness Index scores. Good agreement 
between the scores of the geriatrician and the clinical pharmacist was found: the κ values of the 8 questions ranged 
between 0.54 and 0.77 and the overall mean κ value was 0.71. Were found the highest κ values for drug–disease 
interactions (0.77), dosage (0.74), and ADR (0.74), and the lowest values for directions (0.54) and indication (0.65).
Bakken et al.
Norway, 2012(41) 
The prevalence of potentially inappropriate medicines increased from 24% to 35%; concomitant use of ≥ 3 psychotropic/
opioid drugs and drug combinations including non-steroid anti-inflammatory drugs increased significantly. Serious DDI 
were scarce both on admission and discharge (0.7%).
Romana et al.
India, 2012(42)
The drugs involved in majority of the DDI included ciprofloxacin, theophylline, ceftriaxone and azithromycin. ADR were 
mainly seen in 15% of patients. Only certain and probable ADR were taken for analysis. ADR were mainly seen for 
insulin (5 patients), followed by salbutamol (3 patients), amlodipine (2 patients) and digoxin (2 patients).
(the Figure 3 continue in the next page...)
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Were observed 8,615 DDIs in 55% of patients, 48% in nursing homes and 57% in home nursing services. More women 
in home nursing services compared with men were exposed to DDI; however, no significant difference between genders 
was found in nursing homes (48.2% vs. 46.7%). The number of DDIs per patient was significantly correlated with the 




The sample used a median of 5 chronic drugs per patient, and half used psychotropic medication chronically, mainly 
benzodiazepines. In 100 patients (29.6%) at least one DDI of potential clinical significance was observed. The overall 
mean adherence per patient was very high (98.1%), but 39.6% of individuals were un-adherent with at least one 
medication. The participants reported several practical problems with drug taking: difficulties with vision (32.0%), blister 




Were found no increase in the risk of hemorrhage among older patients receiving warfarin who initiated levothyroxine in 
the previous 30 days. As expected, were found no significant association with more distant exposures (adjusted Odds 
ratio 0.76, 95% confidence interval 0.26–2.25 for patients initiating levothyroxine 31–60 days before the index date; 





Seventy ADRs involving 113 drugs were found in 68 (10%) hospitalizations of older veterans, of which 25 (36.8%) were 
preventable. The most common ADRs that occurred were bradycardia, hypoglycemia, falls, and mental status changes. 
The polypharmacy (≥9 and 5–8) was associated with greater risk of ADR-related hospitalization.
Vila et al.
Spain, 2012(47)
In 83 patients (they used 99 benzodiazepines) were detected 132 interactions: 33%  with omeprazole, 19% anxiolytics, 
14% beta-blockers, and 8% with other hypnotics followed of  antidepressants, ketoconazole, fentanyl and ciprofloxacin, 
among others. 278 ADR were found: 32 % memory loss, 21 % drowsiness, 12% lack of coordination, 8.3% dizziness 




DDI-related ADRs were verified in 6.5% of the sample. Twenty-one drugs were involved, and warfarin was the most 
common of these, involved in 11 of the DDI-related ADRs. Gastrointestinal bleeding was the most frequent DDI-related 
ADR hospital admission was necessary in 36.7%. In the non-exposed group, 48 drugs were involved in potential DDIs. 
The age, the number of diagnosed diseases, and the number of drugs consumed were associated with an increased 
risk of DDI-related ADRs. The older adults who took five or more drugs had a significantly higher risk of DDI-related 




The prevalence of clinically important potential DDIs found was 47.4%. Female sex, diagnosis of ≥ 3 diseases, and 
diagnosis of hypertension were associated with potential DDIs. Drug therapy regimens involving ≥ 2 prescribers, ≥ 3 
drugs, ≥ 2 Anatomical Therapeutic Chemical codes, ≥ 2 drugs acting on cytochrome P450, and  Anatomical Therapeutic 











ADRs were directly responsible or contributed to 27 (28.7%) and 13 (17.3%) of definite readmissions in the control group 
and intervention group, respectively. Antithrombotic, antihypertensive, and psychotropic drugs were implicated in 81.5% 




A total number of 77 patients with drug-related problems were identified, contributing to 12.2% of the total study 
population (633 patients). Forty-two drug-related problems (56% of all drug-related problems) were classified under the 
P1 domain “adverse drug reactions”.
Marusic et al.
Croatia, 2013(53)
Potential DDIs were identified in 190 (85.6 %) patients. Actual DDIs were detected in 21 (9.5%) patients. In 19 patients, 





A total of 690 drug-related problem per patient were identified (mean=9.9), 393 (57%) were classified as actual drug-
related problem per patient and 297 (43%) were classified as potential drug-related problem per patient. The three 





361 drug-related problems were detected. The most common types were: potential DDIs (32.4%), ADR (31.6%), and 
patient non-adherence (13.3%). Approximately half (54.0%) of the potential DDIs detected were pharmacokinetic 
interactions. Majority (85.1%) of the ADR detected in this study was associated with chemotherapy.
(the Figure 3 continue in the next page...)
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The medical teams did not recognize 19.9% of all ADRs present upon admission and 20.3% of all ADRs occurring 
during the hospital stay. Unrecognized ADRs were significantly more often ADRs with possible causality, ADRs caused 
by medication errors and ADRs not manifesting as new symptoms. The medical teams did not recognize 23.2% of mild 
to moderately severe ADRs and 16.5% of severe, life-threatening, or fatal ADRs. 
Somers et al.
Belgium, 2013(57)
 The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1,137 drugs. The most 
common underlying drug-related problem concerned incorrect dose (31%), DDI (20%), and ADR (15%) which appeared 
most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. 
The criteria with the highest (most inappropriate) scores were DDI, dosage, and drug choice, both for the calculation 
before and after the recommendation. 
Figure 3 – Summary of results of studies on potential DDI and ADR. Brasilia, Federal District, Brazil, 2014
Of the 47 records resulting from the search 
strategies, 24 (51.1%) full-text articles were retrieved 
for review concerning ADR(11-18,20,24-25,28-29,34-36,38-40,46,51-
52,54,56), 14 (29.8%) DDI(21-23,27,30-33,41,43-45,49,53) and nine 
(19.1%) are related to both DDI and ADR(19,26,37,42,47-
48,50,55,57), according to  Figures 2 and 3.
Discussion 
To the best of our knowledge, this is the first 
integrative review examining studies published 
between 2008-2013 on the occurrence of DDIs and 
ADRs specifically among older adults. This study helps 
to demonstrate that the issue in focus is a prevalent 
problem in various countries. However, generalizing the 
results of this review is difficult because of the multiplicity 
of methods and sample sizes of several studies and 
the diversity of locations they were conducted. Some 
aspects are highlighted.
Initially, different definitions of polypharmacy 
were utilized in the studies analyzed such as ≥3(33), 
≥5(19-20,26-27,29,31,37,42,44,46,51), ≥6(52) or ≥10(11-12,15). 
In thirty-one studies there was no definition of 
polypharmacy(13-14,16-18,21-25,28,30,32,34-36,38-41,43,45,47-50,53-57). 
Therefore, there is a need for a clear cut-off point that 
defines polypharmacy worldwide. A definition focusing 
on whether the medication is clinically indicated may 
be more appropriate(9) than the number of ingested 
medicines.
DDI and ADR are frequently the end result of 
polypharmacy as shown in the studies analyzed(11-57), and 
are associated with others predictors, for example: sex 
differences(24,33); sex of patients, alcohol consumption 
and smoking habits(29); increased age(39,49); diagnoses of 
diseases and multiple comorbidities(21,25,48-49,53); use the 
specific types drugs, such as patients using clopidogrel 
with proton pump inhibitors(14-15), tamoxifen(18), co-
prescription of macrolide antibiotics and calcium-channel 
blockers(23),trimethoprim/sulfamethoxazole(17,28,34),antid
epressants(31,36),warfarin(38,45), benzodiazepines(47); also, 
cognitive impairment and various functional problems 
that affect practical drug management capacity(24-25); 
living situation(19); access to health care, prescription of 
drug therapy regimens by two or more prescribers(49); 
and educational status(31,44,50) . 
Non-adherence to treatment is a common problem 
in older adults. DDIs and ADRs during hospitalization 
have been reported to be associated with non-
adherence, which are also common among older adults 
who are discharged from hospital and are using several 
drugs for their chronic diseases. Studies examining 
readmissions due to DDIs and consequent ADRs were 
also performed(44,51,55). Therefore, early detection and 
recognition of clinically important interactions by 
healthcare professionals are vital for monitoring the 
occurrence of DDIs and ADRs in the continuum of health 
care.
Older adults usually do better use of medicines 
when their care is managed by a multidisciplinary 
team, consisting of a physician (geriatrician), clinical 
pharmacist and nurse. The involvement of a dentist in 
this team seems to be relevant, as demonstrated in a 
study(32).
Inappropriate prescription, with misuse of 
medication, poor quality of doctors’ choices of 
prescriptions, over-prescription of drugs, additional 
medicines prescribed to treat side effects, and poor 
team-patient relationships may increase the chances 
of occurrences of DDI and ADR. By combining their 
knowledge and skills, a comprehensive plan and 
dosage adjustments can be developed to enable best 
pharmacotherapy while the risks of DDI and ADR 
are reduced. An efficient communication between 
these professionals and coordination across multiple 
prescribers is crucial for success. Moreover, educational 
programs should be conducted to improve the habit 
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of prescribing rationally. Equally, patient education at 
discharge and follow-up is also very important.
Use of multiple medications increases the risk of 
inappropriate prescribing. Different interventions to 
optimize prescribing appropriateness in older adults, 
for example, the Beers’ criteria, most often used in the 
United States(12,16,20,47), the validated Screening Tool of 
Older Persons’ Potentially Inappropriate Prescriptions 
(STOPP) and Screening Tool to Alert doctors to the 
Right, i.e. appropriate, indicated Treatment (START) 
criteria(11,16,30) in the Ireland and United Kingdom, the 
Norwegian General Practice criteria (NORGEP)(41,43), 
and the instrument Medication Appropriateness Index 
(MAI)(40,57) have been explored in studies. The studies 
reviewed indicated that STOPP/START criteria identified 
a higher proportion of inappropriate prescription than 
Beers’ criteria. 
This review showed that there are different 
frequencies and types of DDIs and ADR, which are 
drug-related problems, associated with different classes 
of drugs. In daily care practice, the correct diagnosis 
of these problems requires skill and expertise of the 
multidisciplinary team, especially when older adults 
present themselves with nonspecific complaints 
and manifestations. To recognize and diagnose this 
undesirable outcome, goals should be set in the 
health care service, highlighting the role of the clinical 
pharmacist, who uses interventions for identification 
and minimization the drug-related problem (DRP), as 
demonstrated in studies(4-57). 
Balancing the risks and benefits of multiple drug 
therapies may be useful in the establishment of rational 
interventions for the safe use of drugs. Accordingly, 
the use of technologies in the monitoring of DDIs and 
recognition of ADRs, such as computer-based screening, 
could help practitioners to recognize potential and 
clinically significant interactions and adverse events. The 
software must have high sensitivity and specificity, and 
high positive and negative predictive value. In the same 
way, the advantage of utilizing computerized databases 
for reviewing the medications’ prescriptions is evident.
Thus, the reviewed studies reinforced the notion 
that polypharmacy is multifactorial and is associated 
with negative health outcomes, as reported previously 
in two studies reviewed(8-9), and in the article of experts 
opinion that present information specifically of 12 
studies about DDI and ADR(58).
One aspect noted and that needs to be investigated 
further, relates to examine how self-medication with 
over-the-counter drugs and complementary medications 
contribute to increases the risk of DDIs and ADRs, 
hospitalization and death of older adults. Other gap 
noted in literature relates to the methods utilized by 
primary care providers when assessing polypharmacy. 
Additionally, little information is available about the 
incidence/prevalence of DDIs and ADRs among older 
adults in developing countries.
So, this review points out the relevance of 
conducting more studies to explore different aspects, 
considering the need to develop preventive practices to 
guarantee the safety of older adults with regard to DDIs 
and ADRs. 
Limitations and strength of study
Firstly, publication bias which cannot be measured 
due to both language and database limitations. Selection 
bias may have occurred because unpublished research 
and/or development were not selected. Possibly, another 
limiting aspect is the lack of methodological assessment 
and risk of bias due to the heterogeneity of the reviewed 
studies. A major strength of this study is rigorous review 
of the literature, specifically on the consequences of 
DDIs and ADRs related to polypharmacy, with diverse 
methodological designs, including studies published 
worldwide.
Conclusion and implications for advanced 
practice in geriatric nursing 
This study has identified that early detection and 
recognition of clinically important DDI and ADR by 
healthcare professionals are vital to identify patients 
who are at higher risk for such events and require 
more cautious pharmacotherapy management to avoid 
negative outcomes. Thus, the potential risk to DDI and 
ADR can be managed by professionals with appropriate 
prescriptions, monitoring, and patient education in the 
continuum of care of older adults, i.e. through best 
practices.
In this sense, the professionalization on advanced 
nursing practice is essential, as a requirement for 
acquisition of knowledge, skills training and skills for 
making safe and effective care decisions, for example, 
aimed at health care of older adults commonly exposed 
to polypharmacy. Thus, this integrative review can help 
to increase awareness and discussion, to implement 
universal health coverage and universal access to health 
care of the older adults in order to guarantee the quality 
of care by geriatric nurses.
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